ArticleBlood advances2019

The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN.

Lucia Mazzacurati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.